Question 1

What are the potential side effects of duloxetine?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Dose Escalation, Double-Blind Treatment With Duloxetine Hydrochloride Once Daily Dosing for Evaluation of Safety in Major Depression clinical trial (NCT00042575). Contact the study team or your healthcare provider for specific answers.

Question 2

How does duloxetine compare to other treatments I might consider?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Dose Escalation, Double-Blind Treatment With Duloxetine Hydrochloride Once Daily Dosing for Evaluation of Safety in Major Depression clinical trial (NCT00042575). Contact the study team or your healthcare provider for specific answers.

Question 3

What will my weekly visits involve?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Dose Escalation, Double-Blind Treatment With Duloxetine Hydrochloride Once Daily Dosing for Evaluation of Safety in Major Depression clinical trial (NCT00042575). Contact the study team or your healthcare provider for specific answers.

Question 4

How long will I need to participate in this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Dose Escalation, Double-Blind Treatment With Duloxetine Hydrochloride Once Daily Dosing for Evaluation of Safety in Major Depression clinical trial (NCT00042575). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Dose Escalation, Double-Blind Treatment With Duloxetine Hydrochloride Once Daily Dosing for Evaluation of Safety in Major Depression clinical trial (NCT00042575). Contact the study team or your healthcare provider for specific answers.

Question 6

Is there any chance that duloxetine might not help my depression?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Dose Escalation, Double-Blind Treatment With Duloxetine Hydrochloride Once Daily Dosing for Evaluation of Safety in Major Depression clinical trial (NCT00042575). Contact the study team or your healthcare provider for specific answers.

What this study is about